|
|
Article: Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England.
- Article from:
- PR Newswire
- Article date:
- August 18, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JERUSALEM, August 18 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (http://www.oramed.com/), a developer of alternative drug delivery systems, announced today that Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D. was chosen to present an overview of the clinical development of Oramed's Oral Insulin capsule at Science@BPC of the 2009 British Pharmaceutical Conference ("BPC"), in Manchester, England on September 9, 2009.
Science@BPC is an event that is the result of the collaboration between two organizations, the Royal Pharmaceutical Society of Great Britain and the Academy of Pharmaceutical Sciences. The two organizations describe the event as ...
Related newspaper, magazine, and journal articles:
|
|
Article: Oramed Pharmaceuticals Partners With ETI Karle ...
U.S. Newswire;
September 9, 2008 ;
700+ words
... ... Investor Relation Contacts: Oramed Pharmaceuticals, Eric Rosenberg, Cell ... PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP ... 120 researchers. About Oramed Pharmaceuticals Oramed Pharmaceuticals is ...
|
|